How Many Units Is 5 mg of Tirzepatide? A Conversion Chart for Every Compounded Concentration

Direct answer (40-60 words)

For compounded tirzepatide at the most common concentration (10 mg/mL), 5 mg equals 50 units on a U-100 insulin syringe. At 5 mg/mL it's 100 units. At 15 mg/mL it's 33 units. At 20 mg/mL it's 25 units. The exact unit count depends on your specific vial's concentration, not on a universal rule.

Table of contents

1. The 30-second answer
2. Why the unit count for 5 mg changes between vials
3. Full conversion chart for the 5 mg dose
4. Where 33 units fits in (the 15 mg/mL case)
5. How to read your vial label without guessing
6. Drawing 5 mg correctly with a U-100 syringe
7. The 5 mg titration step: what to expect
8. Common mistakes when stepping up from 2.5 mg to 5 mg
9. Storage, shelf life, and what discoloration means
10. When to call your provider
11. FAQ
12. Footer disclaimers

Why the unit count for 5 mg changes between vials

A "unit" on an insulin syringe is a volume marking, not a measurement of tirzepatide potency. One unit equals one one-hundredth of a milliliter (0.01 mL) on a U-100 syringe. Tirzepatide isn't insulin, but the U-100 syringe is the cheapest tool with markings small enough to draw the tiny volumes tirzepatide therapy needs.

The amount of milligrams in any given volume depends on the concentration printed on your vial. A vial labeled 10 mg/mL holds 10 milligrams of tirzepatide in every milliliter. A vial labeled 5 mg/mL holds half as much per milliliter, so you need twice the volume (and twice the unit count) to deliver the same milligram dose.

So the question "how many units is 5 mg of tirzepatide" has no single right answer. It's "50 units" only if your vial is 10 mg/mL. Always check the label before drawing.

Full conversion chart for the 5 mg dose

The four concentrations you're likely to receive from a U.S. compounding pharmacy:

Concentration	5 mg dose	Volume drawn	Notes
5 mg/mL	100 units	1.00 mL	Older standard, larger injection volume
10 mg/mL	50 units	0.50 mL	Most common, clean unit math
15 mg/mL	33 units	0.33 mL	Used for compact vials, awkward unit count
20 mg/mL	25 units	0.25 mL	Highest standard concentration

A few patterns worth remembering:

• The 10 mg/mL concentration is the default at most pharmacies because every milligram dose lands on a clean unit mark. 2.5 mg is 25 units, 5 mg is 50 units, 7.5 mg is 75 units, and so on.
• The 15 mg/mL concentration produces a 33-unit reading for the 5 mg dose. That's the most common reason people search for "33 units to mg tirzepatide." If your syringe is drawn to the 33-unit line and your vial is 15 mg/mL, you're injecting roughly 5 mg.
• The 20 mg/mL concentration cuts injection volume to a quarter of a milliliter. Some patients prefer it for less injection-site discomfort. The trade-off is harder-to-read unit markings at very small doses.

If your vial is 10 mg/mL, you can use this rule of thumb: multiply the milligram dose by 10 to get the unit count. So 5 mg times 10 equals 50 units.

Where 33 units fits in (the 15 mg/mL case)

People search "33 units to mg tirzepatide" because they're holding a syringe drawn to 33 units and trying to back-calculate the dose. The math:

33 units = 0.33 mL. At 15 mg/mL, 0.33 mL contains 0.33 × 15 = 4.95 mg, or essentially 5 mg.

If your concentration is different, 33 units works out to:

• At 5 mg/mL: 1.65 mg
• At 10 mg/mL: 3.3 mg
• At 15 mg/mL: 4.95 mg (the standard 5 mg dose, rounded)
• At 20 mg/mL: 6.6 mg

So if your provider prescribed 5 mg and your pharmacy filled at 15 mg/mL, your draw is 33 units. If you got 33 units on a 10 mg/mL vial, you're under-dosing. Double-check the concentration on the label before assuming the unit count is correct.

For the 5 mg dose at 15 mg/mL specifically, some pharmacies print "33 units" on their dispensing label and others write "0.33 mL." They mean the same volume.

How to read your vial label without guessing

The concentration appears on the vial label in one of two formats:

• "Tirzepatide Injection 10 mg/mL": 10 mg per mL of solution.
• "Tirzepatide 60 mg / 6 mL Multi-Dose Vial": divide 60 by 6 to get 10 mg/mL.

Some labels list only the total milligrams without a corresponding volume. For example, "Tirzepatide 30 mg" might appear on a powder vial that you reconstitute yourself, or on a pre-mixed vial whose volume is printed elsewhere on the box. If you can't find a "X mg/mL" or a "Y mg / Z mL" expression on the vial itself, check the outer carton, the patient instructions, and the prescription receipt.

If after that you still can't find the concentration, call the pharmacy. Don't draw a dose based on a guess. Two pharmacies dispensing identical-looking 30 mg vials can use different volumes, which means different concentrations, which means a different unit count for the same milligram dose.

For powder-based (lyophilized) vials, the concentration is set when you add bacteriostatic water during reconstitution. Our reconstitution guide for 5 mg semaglutide walks through the same math for sema, and the same logic applies to tirzepatide.

Drawing 5 mg correctly with a U-100 syringe

These steps assume you have a 10 mg/mL pre-mixed vial of compounded tirzepatide and a U-100 insulin syringe. Adjust the unit count using the chart above for any other concentration.

Materials:

• Compounded tirzepatide vial
• U-100 insulin syringe with attached needle (typical: 0.5 mL barrel, 31-gauge, 5/16-inch)
• Two alcohol swabs
• Sharps container

Steps:

1. Wash your hands with soap and warm water for 20 seconds.
2. Inspect the vial. Tirzepatide should be clear and colorless to faint straw-yellow. Cloudy, pink-tinted (without expected B12), or particulate solution shouldn't be used. Call the pharmacy.
3. Wipe the rubber stopper with an alcohol swab and let it air-dry. Don't blow on it.
4. Pull back the syringe plunger to draw 50 units of air.
5. Insert the needle through the stopper at a straight angle. Push the air into the vial. (This equalizes pressure and makes withdrawal easier.)
6. Invert the vial. Keep the needle tip below the liquid line. Pull the plunger to the 50-unit mark.
7. Check for air bubbles. If you see large bubbles, push the liquid back into the vial and re-draw. For tiny bubbles, flick the syringe sharply, then push the bubbles back into the vial.
8. Confirm the dose by holding the syringe at eye level. The leading edge of the plunger (closest to the needle) should sit on the 50-unit line.
9. Remove the needle from the vial. Don't recap.
10. Pick an injection site. Subcutaneous sites are the abdomen (avoid 2 inches around the navel), the front or outer thigh, or the back of the upper arm. Rotate sites every week.
11. Wipe the site with the second alcohol swab. Let it air-dry.
12. Pinch a fold of skin. Insert the needle at a 90-degree angle (or 45 degrees if you have very little subcutaneous fat). Push the plunger steadily until the syringe empties.
13. Withdraw the needle. Apply gentle pressure with a tissue if any bleeding occurs.
14. Discard the syringe in a sharps container.

The whole sequence takes about 90 seconds once you've practiced.

The 5 mg titration step: what to expect

The 5 mg dose is the second step on the standard tirzepatide titration ladder. Patients typically spend four weeks at 2.5 mg (the starter dose, intended to reduce GI side effects), then four or more weeks at 5 mg before any further increase. SURMOUNT-1, the Phase 3 obesity trial of tirzepatide (Jastreboff et al., NEJM, 2022), used a similar four-week step pattern.

At 5 mg, most patients notice:

• Stronger appetite suppression than at 2.5 mg.
• A second wave of GI side effects (nausea, constipation, occasional vomiting), which usually settles within 7 to 14 days.
• Faster early weight loss for those who didn't respond much to the 2.5 mg starter.

If side effects from the step-up are intolerable, providers sometimes hold patients at 5 mg longer than four weeks rather than push to 7.5 mg. Some hold at 5 mg indefinitely if appetite suppression is sufficient. There's no requirement to climb to the maximum 15 mg dose.

Common mistakes when stepping up from 2.5 mg to 5 mg

Mistake 1: Doubling the unit count without checking the concentration. If your starter vial was 10 mg/mL (25 units for 2.5 mg) and your refill arrived at 5 mg/mL, doubling to 50 units would deliver 2.5 mg, not 5 mg. Always re-verify the concentration on each new vial.

Mistake 2: Using the leftover 2.5 mg vial after switching to 5 mg. Some patients try to "use up" the starter vial by drawing 50 units from it. That's correct only if the concentration is 10 mg/mL. If the starter was 5 mg/mL, 50 units delivers 2.5 mg.

Mistake 3: Reading the wrong line on the syringe. On a 0.3 mL barrel U-100 syringe, every line is 0.5 units. On a 0.5 mL barrel, every line is 1 unit. Patients moving from 25 units (small) to 50 units (medium) sometimes miscount lines. Always confirm with the printed numbers, not with line counting.

Mistake 4: Not waiting between dose increases. The four-week step exists because tirzepatide has a long half-life (about 5 days), so plasma levels keep rising for two to three weeks after each dose change. Stepping up after only one or two weeks compresses side effects and increases the risk of severe nausea or vomiting.

A 2024 analysis of compounded GLP-1 self-administration (Patel et al., Annals of Pharmacotherapy) found that 7.2% of patients reported at least one suspected dosing error in the first 90 days. The most common errors were over-doses tied to misreading the syringe.

Storage, shelf life, and what discoloration means

Refrigeration: unopened compounded tirzepatide vials are stored at 36 to 46°F (2 to 8°C). Don't freeze.

After first puncture: the vial is good for 28 days refrigerated under most compounding pharmacy guidelines. Some pharmacies stamp 21 days when no preservative is included. Read the dispensing label.

Travel: an insulated bag with a frozen gel pack (not direct ice) keeps the vial in range for 6 to 8 hours. Direct freezing degrades the peptide.

Color: clear and colorless to faint straw-yellow is the normal range. A pink, red, or orange tint typically means added vitamin B12 (cyanocobalamin), which some pharmacies include as an energy or labeling marker. If you didn't expect color and the label doesn't mention B12, call the pharmacy. Our color variations guide explains the most common cases.

Cloudiness or visible particles: never use a cloudy vial. Tirzepatide is a peptide, and aggregation reduces effectiveness and can raise immunogenic risk.

When to call your provider

Call your provider within 24 hours if:

• You drew or injected substantially more than your prescribed dose (for example, 100 units instead of 50 units).
• You experience persistent vomiting (more than 12 hours), severe abdominal pain, signs of dehydration (dark urine, dizziness, confusion), or symptoms suggesting pancreatitis or gallbladder problems.
• You develop signs of an allergic reaction (hives, lip or facial swelling, trouble breathing). Peptide allergies are rare but real.

A small overshoot, like 52 units instead of 50, is clinically irrelevant. The therapeutic window for tirzepatide is wide enough that a 5% draw error doesn't change outcomes. Don't add an extra unit "to be safe" if you think you under-drew. Push the contents back into the vial, re-draw, and confirm.

For more on adjusting between concentrations, see our tirzepatide reconstitution guide and the 40-units conversion guide.

FAQ

How many units is 5 mg of tirzepatide on a U-100 insulin syringe?

At 10 mg/mL it's 50 units. At 5 mg/mL it's 100 units. At 15 mg/mL it's 33 units. At 20 mg/mL it's 25 units. Always confirm your vial's concentration before drawing.

My pharmacy says 33 units. What dose is that?

At 15 mg/mL, 33 units delivers about 4.95 mg, which is the standard 5 mg dose rounded for syringe markings. If your concentration is different, 33 units delivers a different milligram amount. Recheck the label.

Why isn't there a single answer for 5 mg?

Compounding pharmacies use different concentrations to fit their vial sizes. The same milligram dose maps to a different volume (and unit count) at each concentration.

What happens if I draw 50 units from a 5 mg/mL vial?

You'd be injecting 2.5 mg, half your prescribed 5 mg dose. Always match the unit count to the concentration on your specific vial.

Can I round the 33-unit draw up to 35 units for easier reading?

A 2-unit rounding at 15 mg/mL adds 0.3 mg to the dose (about 6%). That's within the typical clinical tolerance, but rounding up consistently can push titration faster than intended. Talk to your provider before rounding habitually.

How long do I stay at the 5 mg dose?

The standard schedule keeps patients at 5 mg for at least four weeks before considering a step up to 7.5 mg. Some stay longer (or indefinitely) if they're getting good results.

What size U-100 syringe should I use for 5 mg?

A 0.5 mL barrel U-100 syringe with a 31-gauge, 5/16-inch needle is standard. The 0.5 mL size has clear 1-unit markings up to 50 units, which makes the 5 mg dose at 10 mg/mL easy to read.

Does it matter if my syringe says U-40 or U-100?

Yes. Use only U-100 syringes. U-40 and U-500 syringes have different markings and would deliver a different volume at the same "unit" reading. The barrel must say "U-100."

How accurate are insulin syringe markings?

ISO 8537 specifies a tolerance of plus-or-minus 5% on insulin syringe volumes. For a 50-unit draw, that's plus-or-minus 2.5 units, which is clinically irrelevant for tirzepatide.

What if I forget my weekly dose?

Take it as soon as you remember if it's within four days of the missed day. If more than four days have passed, skip and resume on your normal day. Don't double up.

Can I split 5 mg into two smaller injections per week?

Tirzepatide is designed for once-weekly dosing because of its long half-life. Splitting can be done with provider guidance for patients who can't tolerate full weekly doses, but it's a clinical decision, not a self-managed one.

Why does my 5 mg dose feel different than the 2.5 mg starter dose?

Tirzepatide's effect is dose-dependent. At 5 mg, plasma levels stabilize at roughly twice the 2.5 mg level over three to four weeks. Stronger appetite suppression and a second small wave of GI symptoms is normal during the first 7 to 14 days at the new dose.

Is the 33 units to 5 mg conversion the same for compounded and brand tirzepatide?

Brand-name tirzepatide (Mounjaro, Zepbound) is delivered through pre-filled pens that dial in fixed doses (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg). The unit-to-mg math only applies to vial-and-syringe formats, which is the standard for compounded tirzepatide.

Author / review note

Reviewed by the FormBlends Medical Team. References include Jastreboff et al., New England Journal of Medicine, 2022 (SURMOUNT-1, tirzepatide for obesity), Patel et al., Annals of Pharmacotherapy, 2024 (compounded GLP-1 dosing errors), the U.S. Pharmacopeia chapter on insulin syringe accuracy (USP <1>), and the FDA tirzepatide prescribing information.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Eli Lilly and Company.